BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Zhang C, Tie H, Luo J, Wang Y, Wu Q. miR-760 exerts an antioncogenic effect in esophageal squamous cell carcinoma by negatively driving fat metabolism via targeting c-Myc. J Cell Biochem 2020;121:2950-61. [PMID: 31709636 DOI: 10.1002/jcb.29540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Yan C, Zhang P, Li G, Zhu R, Wang H, Wu L, Xu G. Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways. Front Oncol 2021;11:757541. [PMID: 34858831 DOI: 10.3389/fonc.2021.757541] [Reference Citation Analysis]
2 Huang X, Huang M, Chen M, Chen X. lncRNA SLC9A3-AS1 Promotes Oncogenesis of NSCLC via Sponging microRNA-760 and May Serve as a Prognosis Predictor of NSCLC Patients. CMAR 2022;Volume 14:1087-98. [DOI: 10.2147/cmar.s352308] [Reference Citation Analysis]
3 Zhang X, Ma L, Zhai L, Chen D, Li Y, Shang Z, Zhang Z, Gao Y, Yang W, Li Y, Pan Y. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Int J Med Sci 2021;18:984-99. [PMID: 33456356 DOI: 10.7150/ijms.49126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Hashemi F, Samarghandian S, Najafi M. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer. Life Sci 2020;256:117973. [PMID: 32569779 DOI: 10.1016/j.lfs.2020.117973] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]